Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cardinal Health ( (CAH) ) has provided an update.
On October 30, 2025, Cardinal Health reported a 22% increase in first-quarter fiscal year 2026 revenues, reaching $64 billion. The company’s non-GAAP operating earnings rose 37% to $857 million, driven by growth across all five operating segments. The company raised its fiscal 2026 non-GAAP EPS guidance and adjusted free cash flow outlook, reflecting strong financial performance and strategic execution. Cardinal Health also announced the anticipated completion of its acquisition of Solaris Health in early November, which is expected to bolster its market position.
The most recent analyst rating on (CAH) stock is a Buy with a $190.00 price target. To see the full list of analyst forecasts on Cardinal Health stock, see the CAH Stock Forecast page.
Spark’s Take on CAH Stock
According to Spark, TipRanks’ AI Analyst, CAH is a Neutral.
Cardinal Health’s overall stock score is driven by strong earnings growth and strategic acquisitions, which are expected to enhance future performance. However, significant financial leverage and cash flow management issues present risks. The technical indicators suggest a mild bullish trend, while the valuation appears relatively high, limiting upside potential.
To see Spark’s full report on CAH stock, click here.
More about Cardinal Health
Cardinal Health operates in the healthcare industry, providing pharmaceuticals, medical products, and services. The company focuses on pharmaceutical and specialty solutions, as well as global medical products and distribution, serving a broad range of healthcare providers and manufacturers.
Average Trading Volume: 2,392,779
Technical Sentiment Signal: Buy
Current Market Cap: $39.08B
For an in-depth examination of CAH stock, go to TipRanks’ Overview page.